This HTML5 document contains 111 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
n10http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33438511
rdf:type
wikibase:Item
schema:description
מאמר מדעי artykuł naukowy artikull shkencor บทความทางวิทยาศาสตร์ article scientifique (publié 1989) научная статья 1989 թվականի նոյեմբերին հրատարակված գիտական հոդված 1989年論文 vitskapeleg artikkel наукова стаття, опублікована в листопаді 1989 scientific article tudományos cikk article científic 1989年论文 teaduslik artikkel tieteellinen artikkeli სამეცნიერო სტატია 1989年の論文 vetenskaplig artikel научни чланак vědecký článek 1989年论文 videnskabelig artikel (udgivet 1989) 1989 nî lūn-bûn سائنسی مضمون article scientific мақолаи илмӣ artikulong pang-agham articol științific mokslinis straipsnis 1989年论文 1989年論文 bilimsel makale wetenschappelijk artikel 1989年论文 1989年論文 ১৯৮৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ مقالهٔ علمی مقالة علمية мақолаи илмӣ vedecký článok επιστημονικό άρθρο научна статия 1989년 논문 artículu científicu espublizáu en 1989 1989年論文 1989 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած 1989年论文 1989年論文 научни чланак vitenskapelig artikkel artigo científico (publicado na 1989) bài báo khoa học naučni članak wissenschaftlicher Artikel articolo scientifico artigo científico (publicado na 1989) artículo científico publicado en 1989 artigo científico scienca artikolo 1989年论文
p:P577
wds:Q33438511-1695147C-F939-483A-A697-8290DB71FE19
wdt:P577
1989-11-01T00:00:00Z
p:P407
wds:Q33438511-A4F461A0-0270-4F68-ACFC-F3D0E9D11742
wdt:P407
wd:Q1860
p:P2093
wds:Q33438511-C54C82DC-ABC6-4B21-8FD8-C72DCA22AC1F wds:Q33438511-E2BCF852-36C0-4ECD-863C-777655BB6670 wds:Q33438511-F5167F81-75FF-419C-AF67-ECE41BE77A32 wds:Q33438511-75614B49-730A-4560-A986-2898E8B5F2DB wds:Q33438511-45209FE1-F406-4EA1-8598-A7A67E48B999 wds:Q33438511-5605CAEF-1F83-4C47-93BC-8A40C0C8AA2A wds:Q33438511-9CCB301B-6C21-459B-AA46-ECE3FD411B50 wds:Q33438511-141387DB-F00A-4FFC-9332-F204738C0A5A wds:Q33438511-329A0788-59F0-4713-8945-829AA20AE50C
wdt:P2093
J L Murray J M Rothberg R Benjamin D Levitt M Talpaz N Papadopoulos J Gutterman K H Lee C Plager
rdfs:label
Concomitant administration of recombinant human interleukin-2 and recombinant interferon alpha-2A in cancer patients: a phase I study Concomitant administration of recombinant human interleukin-2 and recombinant interferon alpha-2A in cancer patients: a phase I study Concomitant administration of recombinant human interleukin-2 and recombinant interferon alpha-2A in cancer patients: a phase I study
skos:prefLabel
Concomitant administration of recombinant human interleukin-2 and recombinant interferon alpha-2A in cancer patients: a phase I study Concomitant administration of recombinant human interleukin-2 and recombinant interferon alpha-2A in cancer patients: a phase I study Concomitant administration of recombinant human interleukin-2 and recombinant interferon alpha-2A in cancer patients: a phase I study
schema:name
Concomitant administration of recombinant human interleukin-2 and recombinant interferon alpha-2A in cancer patients: a phase I study Concomitant administration of recombinant human interleukin-2 and recombinant interferon alpha-2A in cancer patients: a phase I study Concomitant administration of recombinant human interleukin-2 and recombinant interferon alpha-2A in cancer patients: a phase I study
p:P1476
wds:Q33438511-79AD57E3-4B55-40F2-A49F-A7262DFAE704
wdt:P1476
Concomitant administration of recombinant human interleukin-2 and recombinant interferon alpha-2A in cancer patients: a phase I study
p:P304
wds:Q33438511-9CC98304-388E-459E-B15C-DE4AAF9E09BB
wdt:P304
1726-1732
p:P31
wds:Q33438511-B0B00E82-76F0-4A72-BDBB-24AC3D887303
wdt:P31
wd:Q13442814
p:P698
wds:Q33438511-63088C1D-741B-4716-92C1-48272E91621B
wdtn:P698
n12:2809685
wdt:P698
2809685
p:P1433
wds:Q33438511-CD913A82-9D8A-4099-9B31-5DD05300829C
wdt:P1433
wd:Q400292
p:P433
wds:Q33438511-3C53E2D6-22DD-4E9A-8707-6142F583E506
p:P478
wds:Q33438511-3B9FA05D-8101-4C46-862D-7EFB519CE447
wdt:P433
11
wdt:P478
7
p:P356
wds:Q33438511-E07C54ED-8C66-4B01-A780-7BE5ED235F0A
wdtn:P356
n10:JCO.1989.7.11.1726
wdt:P356
10.1200/JCO.1989.7.11.1726